You are here

Gentris Corporation

Company Information
Address
133 SOUTHCENTER CT STE 400
MORRISVILLE, NC 27560-8537
United States



Information

UEI: N/A

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Development of a FISH-Based HPV-Associated Cancer Detection Test

    Amount: $645,892.00

    DESCRIPTION (provided by applicant): A causative role of high-risk human papillomavirus (HPV) types in human cancer has been established, particularly for those of the anogenital region including cerv ...

    SBIRPhase II2012Department of Health and Human Services National Institutes of Health
  2. Development and Validation of a FISH-Based Renal Cancer Detection Assay

    Amount: $645,168.00

    DESCRIPTION (provided by applicant): Increased routine use of state-of-the-art imaging techniques has resulted in a higher incidence of small incidentally discovered renal masses, benign and malignant ...

    SBIRPhase II2010Department of Health and Human Services National Institutes of Health
  3. Development of a FISH-Based HPV-Associated Cancer Detection Test

    Amount: $99,565.00

    DESCRIPTION (provided by applicant): A causative role of high-risk human papillomavirus (HPV) types in human cancer has been established, particularly for those of the anogenital region including cerv ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  4. Development and Validation of a FISH-Based Renal Cancer Detection Assay

    Amount: $93,253.00

    DESCRIPTION (provided by applicant): Increased routine use of state-of-the-art imaging techniques has resulted in a higher incidence of small incidentally discovered renal masses, benign and malignant ...

    SBIRPhase I2008Department of Health and Human Services National Institutes of Health
  5. HIGH THROUGHPUT SYSTEM FOR FISH ANALYSIS

    Amount: $186,145.00

    Minimum Residual Disease (MRD) is currently identified using pathologic examination, cytogenetics, fluorescence activated cell sorting, and polymerase chain reaction (PCR). Pathologic examination, whi ...

    SBIRPhase I2002Department of Health and Human Services National Institutes of Health
  6. FISH ASSAY FOR THE DETECTION OF T (14;18) (Q32;21)

    Amount: $0.00

    DESCRIPTION (applicant's abstract): Approximately 60 percent of B-cell lymphomas are characterized by the presence of the t(14;18) (q32;q21) chromosomal translocation. Dia ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  7. FISH ASSAY FOR THE DETECTION OF T (14;18) (Q32;21)

    Amount: $417,956.00

    DESCRIPTION (applicant's abstract): Approximately 60 percent of B-cell lymphomas are characterized by the presence of the t(14;18) (q32;q21) chromosomal translocation. Dia ...

    SBIRPhase II2001Department of Health and Human Services National Institutes of Health
  8. MOLECULAR PROBES FOR BURKITT'S AND MANTLE CELL LYMPHOMA

    Amount: $158,425.00

    APPLICANT?S DESCRIPTION: The goal of this research is to develop two fluorescence in situ hybridization (FISH) assays for the detection of the t(11;14)(q13;q32) and the t(8;14)(q24;q32) chromosomal tr ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  9. FISH Assay for Acute Myeloid Leukemia

    Amount: $226,508.00

    DESCRIPTION (Applicant's abstract): The goal of this research is to develop two fluorescence in situ hybridization (FISH) assays for detecting the t(8;21)(q22;q22) and inv(16)(p ...

    SBIRPhase I2001Department of Health and Human Services National Institutes of Health
  10. N/A

    Amount: $132,371.00

    N/A

    SBIRPhase I2000Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government